Recently, the stabilization or overactivation of the HIF-1α signalling pathway, reflecting peripheral nerve hypoxia, has been similarly linked to the pathogenesis of both bortezomib- or paclitaxel-induced peripheral neuropathy (Ludman & Melemedjian, 2019; Kober et al, 2020). This evidence concerns the gene HIF1A and peripheral neuropathy.